Literature DB >> 24619420

β-amyloid fibrils in Alzheimer disease are not inert when bound to copper ions but can degrade hydrogen peroxide and generate reactive oxygen species.

Jennifer Mayes1, Claire Tinker-Mill, Oleg Kolosov, Hao Zhang, Brian J Tabner, David Allsop.   

Abstract

According to the "amyloid cascade" hypothesis of Alzheimer disease, the formation of Aβ fibrils and senile plaques in the brain initiates a cascade of events leading to the formation of neurofibrillary tangles, neurodegeneration, and the symptom of dementia. Recently, however, emphasis has shifted away from amyloid fibrils as the predominant toxic form of Aβ toward smaller aggregates, referred to as "soluble oligomers." These oligomers have become one of the prime suspects for involvement in the early oxidative damage that is evident in this disease. This raises the question whether or not Aβ fibrils are actually "inert tombstones" present at the end of the aggregation process. Here we show that, when Aβ(1-42) aggregates, including fibrils, are bound to Cu(II) ions, they retain their redox activity and are able to degrade hydrogen peroxide (H2O2) with the formation of hydroxyl radicals and the consequent oxidation of the peptide (detected by formation of carbonyl groups). We find that this ability increases as the Cu(II):peptide ratio increases and is accompanied by changes in aggregate morphology, as determined by atomic force microscopy. When aggregates are prepared in the copresence of Cu(II) and Zn(II) ions, the ratio of Cu(II):Zn(II) becomes an important factor in the degeneration of H2O2, the formation of carbonyl groups in the peptide, and in aggregate morphology. We believe, therefore, that Aβ fibrils can destroy H2O2 and generate damaging hydroxyl radicals and, so, are not necessarily inert end points.

Entities:  

Keywords:  Alzheimer Disease; Copper Ions; Free Radicals; Hydrogen Peroxide; Oxidative Stress; Peptide Aggregation; Reactive Oxygen Species (ROS); Zinc Ions; β-Amyloid

Mesh:

Substances:

Year:  2014        PMID: 24619420      PMCID: PMC4002111          DOI: 10.1074/jbc.M113.525212

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  60 in total

1.  Age-related oxidative modifications of transthyretin modulate its amyloidogenicity.

Authors:  Lei Zhao; Joel N Buxbaum; Natàlia Reixach
Journal:  Biochemistry       Date:  2013-03-04       Impact factor: 3.162

2.  Hydrogen peroxide is generated during the very early stages of aggregation of the amyloid peptides implicated in Alzheimer disease and familial British dementia.

Authors:  Brian J Tabner; Omar M A El-Agnaf; Stuart Turnbull; Matthew J German; Katerina E Paleologou; Yoshihito Hayashi; Leanne J Cooper; Nigel J Fullwood; David Allsop
Journal:  J Biol Chem       Date:  2005-09-01       Impact factor: 5.157

3.  Protein carbonyl groups as biomarkers of oxidative stress.

Authors:  Isabella Dalle-Donne; Ranieri Rossi; Daniela Giustarini; Aldo Milzani; Roberto Colombo
Journal:  Clin Chim Acta       Date:  2003-03       Impact factor: 3.786

4.  Binding of zinc(II) and copper(II) to the full-length Alzheimer's amyloid-beta peptide.

Authors:  Vello Tõugu; Ann Karafin; Peep Palumaa
Journal:  J Neurochem       Date:  2008-03       Impact factor: 5.372

Review 5.  A beta oligomers - a decade of discovery.

Authors:  Dominic M Walsh; Dennis J Selkoe
Journal:  J Neurochem       Date:  2007-02-05       Impact factor: 5.372

6.  A stable nonfluorescent derivative of resorufin for the fluorometric determination of trace hydrogen peroxide: applications in detecting the activity of phagocyte NADPH oxidase and other oxidases.

Authors:  M Zhou; Z Diwu; N Panchuk-Voloshina; R P Haugland
Journal:  Anal Biochem       Date:  1997-11-15       Impact factor: 3.365

7.  Thioflavine T interaction with synthetic Alzheimer's disease beta-amyloid peptides: detection of amyloid aggregation in solution.

Authors:  H LeVine
Journal:  Protein Sci       Date:  1993-03       Impact factor: 6.725

Review 8.  Bioinorganic chemistry of copper and zinc ions coordinated to amyloid-beta peptide.

Authors:  Peter Faller; Christelle Hureau
Journal:  Dalton Trans       Date:  2008-11-26       Impact factor: 4.390

Review 9.  Neurodegenerative diseases and oxidative stress.

Authors:  Kevin J Barnham; Colin L Masters; Ashley I Bush
Journal:  Nat Rev Drug Discov       Date:  2004-03       Impact factor: 84.694

10.  Solution 1H NMR investigation of Zn2+ and Cd2+ binding to amyloid-beta peptide (Abeta) of Alzheimer's disease.

Authors:  Christopher D Syme; John H Viles
Journal:  Biochim Biophys Acta       Date:  2005-10-14
View more
  28 in total

Review 1.  Neurotoxicity Linked to Dysfunctional Metal Ion Homeostasis and Xenobiotic Metal Exposure: Redox Signaling and Oxidative Stress.

Authors:  Carla Garza-Lombó; Yanahi Posadas; Liliana Quintanar; María E Gonsebatt; Rodrigo Franco
Journal:  Antioxid Redox Signal       Date:  2018-03-28       Impact factor: 8.401

Review 2.  From Molecular Circuit Dysfunction to Disease: Case Studies in Epilepsy, Traumatic Brain Injury, and Alzheimer's Disease.

Authors:  Chris G Dulla; Douglas A Coulter; Jokubas Ziburkus
Journal:  Neuroscientist       Date:  2015-05-06       Impact factor: 7.519

3.  Development of multifunctional heterocyclic Schiff base as a potential metal chelator: a comprehensive spectroscopic approach towards drug discovery.

Authors:  Manojkumar Jadhao; Chayan Das; Anoop Rawat; Himank Kumar; Ritika Joshi; Sudipta Maiti; Sujit Kumar Ghosh
Journal:  J Biol Inorg Chem       Date:  2016-11-07       Impact factor: 3.358

4.  Amyloids, melanins and oxidative stress in melanomagenesis.

Authors:  Feng Liu-Smith; Carrie Poe; Patrick J Farmer; Frank L Meyskens
Journal:  Exp Dermatol       Date:  2014-11-18       Impact factor: 3.960

5.  Glycation of Lys-16 and Arg-5 in amyloid-β and the presence of Cu2+ play a major role in the oxidative stress mechanism of Alzheimer's disease.

Authors:  Sebastian M Fica-Contreras; Sydney O Shuster; Nathaniel D Durfee; Gregory J K Bowe; Nathaniel J Henning; Staci A Hill; Geoffrey D Vrla; David R Stillman; Kelly M Suralik; Roger K Sandwick; Sunhee Choi
Journal:  J Biol Inorg Chem       Date:  2017-10-16       Impact factor: 3.358

Review 6.  Polyphenols as Potential Metal Chelation Compounds Against Alzheimer's Disease.

Authors:  Johant Lakey-Beitia; Andrea M Burillo; Giovanni La Penna; Muralidhar L Hegde; K S Rao
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472

7.  On the generation of OH(·) radical species from H2O2 by Cu(I) amyloid beta peptide model complexes: a DFT investigation.

Authors:  Tommaso Prosdocimi; Luca De Gioia; Giuseppe Zampella; Luca Bertini
Journal:  J Biol Inorg Chem       Date:  2015-12-28       Impact factor: 3.358

Review 8.  Dantrolene, a treatment for Alzheimer disease?

Authors:  Li Liang; Huafeng Wei
Journal:  Alzheimer Dis Assoc Disord       Date:  2015 Jan-Mar       Impact factor: 2.703

9.  Inhibition of copper-mediated aggregation of human γD-crystallin by Schiff bases.

Authors:  Priyanka Chauhan; Sai Brinda Muralidharan; Anand Babu Velappan; Dhrubajyoti Datta; Sanjay Pratihar; Joy Debnath; Kalyan Sundar Ghosh
Journal:  J Biol Inorg Chem       Date:  2017-01-05       Impact factor: 3.358

Review 10.  Metal Toxicity Links to Alzheimer's Disease and Neuroinflammation.

Authors:  Tee Jong Huat; Judith Camats-Perna; Estella A Newcombe; Nicholas Valmas; Masashi Kitazawa; Rodrigo Medeiros
Journal:  J Mol Biol       Date:  2019-01-18       Impact factor: 5.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.